3 attractive dividend shares I’d buy in February

Watch out for great dividends among companies reporting in February.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

dividend scrabble piece spelling

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

I reckon that what marks out the best investors from the rest is successfully finding reliable dividends. Here are three big payers with results coming up in February:

Soft and fluffy

Shares in home furnishings retailer Dunelm Group (LSE: DNLM) have lost 25% in the past 12 months. But they’ve still almost trebled over ten years, and I think what we’ve seen is the common reaction when a growth share starts to slow. Dunelm has posted strong earnings rises for a number of years, but there’s a 7% EPS fall forecast for the year to June 2017, and that’s enough to send a lot of short-termers running for the hills.

A trading update in January reported a further decline in the homewares market, and it helped nudge the shares down a bit further, but the firm did say “we believe that we are continuing to outperform the market as a whole“, and year-on-year sales growth is up 2.8% for the half.

I think what the bears are missing is that Dunelm has been steadily building up its dividend, and is maturing into what I see as a very nice income investment. Dividends are progressive, growing ahead of inflation, and are very well covered by earnings. With a 3.8% yield predicted for the year to June 2017 and 4.2% the year after, I’ll be keenly awaiting first-half results on 8 February.

Emerging markets

I’ve had my eye on Ashmore Group (LSE: ASHM) for some time now, seeing what I think is a bargain in this emerging markets investing specialist. By the end of November the shares had tumbled, but they’ve stabilized since then, and though a forward P/E of 17 might look a little demanding, I think a dividend yield of 5.8% tips Ashmore into ‘buy’ territory.

First-half figures should be released on 9 February, and we’re set to see a fall in assets under management of $2.4bn, with investment performance contributing $1.7bn of that drop. But part of that was down to the strengthening dollar and fallout from the US election, and chief executive Mark Coombs told us that asset prices actually strengthened in December, adding that “accelerating GDP growth, and low allocations all support the expectation of further strong performance in 2017″.

The risk is that the barely-covered dividend might not be maintained, but Ashmore generates a lot of cash, and I can see the company wanting to keep the payments going — I’ll be looking for cash flow and dividend news on the ninth.

Property income

Income from property rental can be lucrative, often more so if it’s commercial property. It’s risky going it alone, but investing in a Real Estate Investment Trust (REIT) can be far safer.

One I’ve been looking at is Primary Health Properties (LSE: PHP), which invests in the healthcare property market — and that’s a very safe one. The company had a portfolio worth £1.2bn at the half-year results stage at 30 June, and it’s acquired a few more properties since then — and 99.7% of its properties are let, which is a very good figure.

The firm’s loan-to-value ratio stood at a little over 50%, so it’s not saddled with too much debt and yet there’s enough gearing there to enhance profits relatively safely.

Oh, and there’s the dividend — set to yield 4.7% for the year just ended, with results due on 16 February, and forecast to rise to 5% by 2018.

Alan Oscroft has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Will the S&P 500 crash in 2026?

The S&P 500 delivered impressive gains in 2025, but valuations are now running high. Are US stocks stretched to breaking…

Read more »

Teenage boy is walking back from the shop with his grandparent. He is carrying the shopping bag and they are linking arms.
Investing Articles

How much do you need in a SIPP to generate a brilliant second income of £2,000 a month?

Harvey Jones crunches the numbers to show how investors can generate a high and rising passive income from a portfolio…

Read more »

Investing Articles

Will Lloyds shares rise 76% again in 2026?

What needs to go right for Lloyds shares to post another 76% rise? Our Foolish author dives into what might…

Read more »

Investing Articles

How much passive income will I get from investing £10,000 in an ISA for 10 years?

Harvey Jones shows how he plans to boost the amount of passive income he gets when he retires, from FTSE…

Read more »

Investing Articles

Down 34% in 2025 — but could this be one of the UK’s top growth stocks for 2026?

With clarity over research funding on the horizon, could Judges Scientific be one of the UK’s best growth stocks to…

Read more »

piggy bank, searching with binoculars
Investing Articles

Can the rampant Barclays share price beat Lloyds in 2026?

Harvey Jones says the Barclays share price was neck and neck with Lloyds over the last year, and checks out…

Read more »

Investing Articles

Here’s how Rolls-Royce shares could hit £25 in 2026

If Rolls-Royce shares continue their recent performance, then £25 might be on the cards for 2026. Let's take a look…

Read more »

Departure & Arrival sign, representing selling and buying in a portfolio
Investing Articles

Prediction: in 2026 the red-hot Rolls-Royce share price could turn £10,000 into…

Harvey Jones can't believe how rapidlly the Rolls-Royce share price has climbed. Now he looks at the FTSE 100 growth…

Read more »